umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Anti-Mullerian hormone and endometrial cancer: a multi-cohort study
Visa övriga samt affilieringar
2017 (Engelska)Ingår i: British Journal of Cancer, ISSN 0007-0920, E-ISSN 1532-1827, Vol. 117, nr 9, s. 1412-1418Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Background: The Mullerian ducts are the embryological precursors of the female reproductive tract, including the uterus; anti-Mullerian hormone (AMH) has a key role in the regulation of foetal sexual differentiation. Anti-Mullerian hormone inhibits endometrial tumour growth in experimental models by stimulating apoptosis and cell cycle arrest. To date, there are no prospective epidemiologic data on circulating AMH and endometrial cancer risk. Methods: We investigated this association among women premenopausal at blood collection in a multicohort study including participants from eight studies located in the United States, Europe, and China. We identified 329 endometrial cancer cases and 339 matched controls. AntiMullerian hormone concentrations in blood were quantified using an enzyme-linked immunosorbent assay. Conditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CI) across tertiles and for a doubling of AMH concentrations (ORlog2). Subgroup analyses were performed by ages at blood donation and diagnosis, oral contraceptive use, and tumour characteristics. Results: Anti-Mullerian hormone was not associated with the risk of endometrial cancer overall (ORlog(2): 1.07 (0.99-1.17)), or with any of the examined subgroups. Conclusions: Although experimental models implicate AMH in endometrial cancer growth inhibition, our findings do not support a role for circulating AMH in the aetiology of endometrial cancer.

Ort, förlag, år, upplaga, sidor
Nature Publishing Group, 2017. Vol. 117, nr 9, s. 1412-1418
Nyckelord [en]
endometrial cancer, anti-Mullerian hormone, Mullerian inhibiting substance, multicohort study
Nationell ämneskategori
Cancer och onkologi
Identifikatorer
URN: urn:nbn:se:umu:diva-141826DOI: 10.1038/bjc.2017.299ISI: 000413527300019PubMedID: 28873086OAI: oai:DiVA.org:umu-141826DiVA, id: diva2:1160224
Tillgänglig från: 2017-11-24 Skapad: 2017-11-24 Senast uppdaterad: 2018-06-09Bibliografiskt granskad

Open Access i DiVA

fulltext(322 kB)30 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 322 kBChecksumma SHA-512
ca7f237cd74fe1aac342a7f82997aa10500136c7f452b93382d782a4e4a3081c7394ea0a7f09723ee1eeaaa9acc49b32e757e2b930c6c391bacede825ad1b44e
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMed

Personposter BETA

Idahl, AnnikaLundin, EvaWeiderpass, Elisabete

Sök vidare i DiVA

Av författaren/redaktören
Idahl, AnnikaLundin, EvaWeiderpass, Elisabete
Av organisationen
Obstetrik och gynekologiInstitutionen för medicinsk biovetenskap
I samma tidskrift
British Journal of Cancer
Cancer och onkologi

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 30 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 131 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf